Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt- And MAPK-independent, NFΚB-dependent manner

Pflugers Archiv European Journal of Physiology

Volumn 459, Issue 4, 2010, Pages 619-630

  Oita, Radu C ^a,b   Ferdinando, Dudley ^a   Wilson, Steve ^a   Bunce, Christopher ^b   Mazzatti, Dawn J ^a,b  

^a UNILEVER RESEARCH   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Adipokine; Inflammation; Insulin resistance; Obesity; ROS; Skeletal muscle

Indexed keywords

I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; RAF PROTEIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME INACTIVATION; ENZYME INHIBITION; GENETIC TRANSCRIPTION AND TRANSLATION; MYOTUBE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; ENZYME INHIBITORS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE FIBERS, SKELETAL; NF-KAPPA B; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES;

EID: 77950919908     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-009-0752-1     Document Type: Article

References (59)

1. Aam BB, Myhre O, Fonnum F (2003) Transcellular signalling pathways and TNF-alpha release involved in formation of reactive oxygen species in rat alveolar macrophages exposed to tertbutylcyclohexane. Arch Toxicol 77(12):678-684
2. Adams JD Jr (2008) Alzheimer's disease, ceramide, visfatin and NAD. CNS Neurol Disord. Drug Targets 7(6):492-498
3. Adya R, Tan BK, Punn A et al (2008) Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatininduced angiogenesis. Cardiovasc Res 78(2):356-365
4. Aldhahi W, Hamdy O (2003) Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep 3(4):293-298
5. Anrather J, Racchumi G, Iadecola C (2006) NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox. J Biol Chem. 281(9):5657-5667
6. Bajwa EK, Yu CL, Gong MN et al (2007) Pre-B-cell colonyenhancing factor gene polymorphisms and risk of acute respiratory distress syndrome. Crit Care Med. 35(5): 1290-1295
7. Bo S, Ciccone G, Baldi I et al (2009) Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers. Nutr Metab Cardiovasc Dis 19(6):423-430
8. Busso N, Karababa M, Nobile M et al (2008) Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS ONE 3(5):e2267
9. 9. Chaldakov GN, Stonkulov IS, Hristova M et al (2003) Adipobiology of disease: adipokines and adipokine-targeted. pharmacology. Curr Pharm Des 9(12): 1023-1031 (Pubitemid 36443203)
10. Dietze D, Koenen M, Röhrig K et al. (2002) Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 51(8):2369-2376
11. Dietze D, Ramrath S, Ritzeler O et al (2004) Inhibitor kappaB kinase is involved in the paracrine crosstalk between human fat and muscle cells. Int J Obes Relat Metab Disord 28(8):985-992
12. 12. Dietze-Schroeder D, Sell H, Uhlig M et al (2005) Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes 54(7):2003-2011 (Pubitemid 40911262)
13. Frydelund-Larsen L, Akerstrom T, Nielsen S et al (2007) Visfatin mRNA expression in human subcutaneous adipose tissue is regulated by exercise. Am J Physiol Endocrinol Metab 292(1): E24-E31
14. Garten A, Petzold S, Körner A et al (2009) Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol Metab 20 (3): 130-138
15. Hong SB, Huang Y, Moreno-Vinasco L et al (2008) Essential role of pre-B-cell colony enhancing factor in ventilator-induced lung injury. Am J Respir Crit Care Med. 178(6):605-617
16. Hug C, Lodish HF (2005) Medicine. Visfatin: a new adipokine. Science 307(5708):366-367
17. Jensen MD (2008) Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol Metab 93(11 Suppl 1): S57-S63
18. Kamiya T, Hara H, Yamada H et al. (2008) Cobalt chloride decreases EC-SOD expression through intracellular ROS generation, and p38-MAPK pathways in COS7 cells. Free Radie Res 42 (11-12):949-956
19. Kim JH, Bachmann RA, Chen J (2009) Interleukin-6 and insulin resistance. Vitam Horm 80:613-633
20. Kim SR, Bae SK, Choi KS et al (2007) Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2. Biochem Biophys Res Commun 357(1):150-156
21. Kim SR, Bae YH, Bae SK et al (2008) Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim Biophys Acta 1783 (5):886-895
22. Krzysik-Walker SM, Ocón-Grove OM, Maddineni SR et al. (2008) Is visfatin an adipokine or myokine? Evidence for greater visfatin expression in skeletal muscle than visceral fat in chickens. Endocrinology 149(4): 1543-1550
23. Ku BM, Lee YK, Jeong JY et al (2007) Ethanol-induced oxidative stress is mediated by p38 MAPK pathway in mouse hippocampal cells. Neurosci Lett 419(1):64-67
24. Lee WJ, Wu CS, Lin H et al (2009) Visfatin-induced expression of inflammatory mediators in human endothelial. cells through the NF-kappaB pathway. Int J Obes (Lond) 33 (4):465-472
25. Li X, Rong Y, Zhang M et al (2009) Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells. Biochem. Biophys Res Commun. 381(4):660-665
26. Lim SY, Davidson SM, Paramanathan AJ et al (2008) The novel adipocytokine visfatin exerts direct cardioprotective effects. J Cell. Mol Med 12(4): 1395-1403
27. Lin BR, Yu CJ, Chen WC et al (2009) Green tea extract supplement reduces D-galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signalling. J Biomed Sci 16(1):35
28. Liu SW, Qiao SB, Yuan JS et al (2009) Visfatin stimulates production of monocyte chemotactic protein-1 and interleukin-6 in human vein umbilical endothelial cells. Horm Metab Res 41 (4):281-286
29. Lorenzo M, Fernández-Veledo S, Vila-Bedmar R et al (2008) Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. J Anim Sci 86(14 Suppl):E94-E104
30. Lovren F, Pan. Y, Shukla PC et al (2009) Visfatin activates eNOS via Akt and MAP kinases and improves endothelial function. Am J Physiol Endocrinol Metab 296(6):.E1440-E1449
31. Martin PR, Shea RJ, Mulks MH (2001) Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence. J Bacteriol 183(4): 1168-1174
32. Moschen AR, Kaser A, Enrich B et al (2007) Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178(3):1748-1758
33. Munhoz CD, Garcia-Bueno B, Madrigal JL et al (2008) Stressinduced neuroinflammation: mechanisms and new pharmacological targets. Braz J Med Biol. Res 41 (12): 1037-1046
34. Myhre O, Sterri SH, Bogen IL et al (2004) Erk1/2 phosphorylation and reactive oxygen, species formation via nitric oxide and Akt-1/Raf-1 crosstalk in cultured rat cerebellar granule cells exposed to the organic solvent 1, 2, 4-trimethylcyclohexane. Toxicol Sci 80(2):296-303
35. Nieto-Vazquez I, Fernández-Veledo S, Krämer DK (2008) Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem 114(3):.183-194 Review
36. 36. Ognjanovic S, Bao S, Yamamoto SY (2001) Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 26(2):107-117 (Pubitemid 32266186)
37. Pajvani UB, Scherer PE (2003) Adiponectin: systemic contributor to insulin sensitivity. Curr Diab Rep 3(3):207-213
38. Rabe K, Lehrke M, Parhofer KG et al (2008) Adipokines and insulin resistance. Mol. Med 14( 11-12):741-751.
39. Revollo JR, Körner A, Mills KF et al (2007) Nampt/PBEF/ Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 6(5):363-375
40. Roncari DA, Hamilton BS (1993) Cellular and molecular factors in adipose tissue growth and obesity. Adv Exp Med Biol 334:269-277
41. Rongvaux A, Andris F, Van Gool F et al (2003) Reconstructing eukaryotic NAD metabolism. Bioessays 25(7):683-690 Review
42. Ronti T, Lupattelli G, Mannarino E (2006) The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 64(4):355-365
43. 43. Samal B, Sun Y, Stearns G et al (1994) Cloning and characterization of the cDNA encoding a novel human pre-B-cell colonyenhancing factor. Mol Cell Biol 14(2): 1431-1437 (Pubitemid 24984261)
44. Seip M, Trygstad O (1996) Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl 413:2-28
45. Sell H, Eckardt K, Taube A (2008) Skeletal muscle insulin resistance induced by adipocyte-conditioned medium.: underlying mechanisms and reversibility. Am J Physiol. Endocrinol Metab 294(6):E1070-E1077
46. Sell H, Eckel J, Dietze-Schroeder D, 2 (2006) Pathways leading to muscle insulin resistance-the muscle - fat connection. Arch Physiol. Biochem 112(2):105-113 Review
47. Sharma AM (2006) The obese patient with diabetes mellitus: from research targets to treatment options. Am J Med 119(5 Suppl 1): S17-S23
48. 48. Skurk T, Alberti-Huber C, Herder C et al (2007) Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92(3): 1023-1033 (Pubitemid 46465679)
49. Song HK, Lee MH, Kim BK et al (2008) Visfatin: a new player in mesangial cell physiology and diabetic nephropathy. Am J Physiol Renal Physiol 295(5):F1485-F1494
50. 50. Sonnenberg GE, Krakower GR, Kissebah AH (2004) A novel pathway to the manifestations of metabolic syndrome. Obes Res 12(2): 180-186 (Pubitemid 41132540)
51. Takebayashi K, Suetsugu M, Wakabayashi S et al (2007) Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism 56 (4):451-458
52. Taki K, Shimozono R, Kusano H et al (2008) Apoptosis signalregulating kinase 1 is crucial for oxidative stress-induced but not for osmotic stress-induced hepatocyte cell death. Life Sci 83(25-26):859-864
53. Viollet B, Mourner R, Leclerc J et al (2007) Targeting AMPactivated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes Metab 33(6):395-402
54. Windelborn JA, Lipton P (2008) Lysosomal release of cathepsins causes ischemic damage in the rat hippocampal slice and depends on NMDA-mediated calcium influx, arachidonic acid metabolism, and free radical production. J Neurochem 106(l):56-69
55. Xiao J, Xiao ZJ, Liu ZG et al (2009) Involvement of dimethylarginine dimethylaminohydrolase-2 in visfatin-enhanced angiogenic function of endothelial cells. Diabetes Metab Res Rev 25 (3):242-249
56. Xie H, Tang SY, Luo XH et al (2007) Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 80(3):201-210
57. Yamawaki H, Hara N, Okada M et al (2009) Visfatin causes endothelium-dependent relaxation in isolated blood vessels. Biochem Biophys Res Commun 383(4):503-508
58. Yu YH, Ginsberg HN (2005) Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res 96(10): 1042-1052
59. Zhang LQ, Adyshev DM, Singleton P et al (2008) Interactions between PBEF and oxidative stress proteins-a potential new mechanism underlying PBEF in the pathogenesis of acute lung injury. FEBS Lett 582(13): 1802-1808